These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 13922689)

  • 21. Selective potentiation of sympathomimetic amines by reserpine. syrosingopine and 2,6-xylylcholine ether bromide (TM-10) in the dog.
    ROSS CA; WENGER HC; LUDDEN CT; STONE CA
    Arch Int Pharmacodyn Ther; 1963 Mar; 142():141-51. PubMed ID: 13975072
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of decarboxylase inhibition on the biosynthesis of brain monoamines.
    BRODIE BB; KUNTZMAN R; HIRSCH CW; COSTA E
    Life Sci (1962); 1962 Mar; 1():81-4. PubMed ID: 13873301
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 24. Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?
    ROSENGREN E
    Acta Physiol Scand; 1960 Aug; 49():364-9. PubMed ID: 13743456
    [No Abstract]   [Full Text] [Related]  

  • 25. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of combined reserpine and ECS on electroshock seizure thresholds in mice.
    Blank DL
    Pharmacol Biochem Behav; 1976 Apr; 4(4):485-7. PubMed ID: 935219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca.
    Hillarp NA; Fuxe K; Dahlström A
    Pharmacol Rev; 1966 Mar; 18(1):727-41. PubMed ID: 5904678
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues.
    Conradi EC; Gaffney TE; Fink DA; Vangrow JS
    J Pharmacol Exp Ther; 1965 Oct; 150(1):26-33. PubMed ID: 5853699
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problem of the preliminary stage of noradrenalin in adrenal cortex and in sympathetic nerve tissue and the problem of the identity of DOPA- and hydroxyphenylserine decarboxylases].
    WERLE E; JUNTGEN-SELL J
    Biochem Z; 1955; 327(4):259-66. PubMed ID: 13328836
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of toxopyrimidine on glutamic-decarboxylase and glutamic-oxalacetic transaminase of rat brain.
    RINDI G; PERRI V; VENTURA U
    Nature; 1959 Apr; 183(4668):1126-7. PubMed ID: 13657025
    [No Abstract]   [Full Text] [Related]  

  • 31. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 32. MONOAMINE LEVELS AND CHOLINE ACETYLASE ACTIVITY IN BRAIN AND EFFECT OF RESERPINE AND DIHYDROXYPHENYLALANINE AFTER CEREBRAL LESIONS.
    BERTLER A; GOTTFRIES CG; NORDENFELT I; ROSENGREN E
    Med Exp Int J Exp Med; 1963; 9():17-9. PubMed ID: 14046720
    [No Abstract]   [Full Text] [Related]  

  • 33. Decarboxylase inhibitors in the treatment of hypertension.
    BREST AN; MOYER JH
    Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878
    [No Abstract]   [Full Text] [Related]  

  • 34. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 35. The therapeutic index of hexafluorodiethyl ether (Indoklon) and its modification by reserpine, chlorpromazine and iproniazid.
    TRUITT EB; EBERSBERGER EM
    Arch Int Pharmacodyn Ther; 1960 Dec; 129():23-35. PubMed ID: 13778275
    [No Abstract]   [Full Text] [Related]  

  • 36. THE EFFECT OF PRENYLAMINE ON THE METABOLISM OF CATECHOL AMINES AND 5-HYDROXYTRYPTAMINE IN BRAIN AND ADRENAL MEDULLA.
    JUORIO AV; VOGT M
    Br J Pharmacol Chemother; 1965 Apr; 24(2):566-73. PubMed ID: 14320870
    [No Abstract]   [Full Text] [Related]  

  • 37. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 38. Is reserpine tranquilization linked to change in brain serotonin or brain norepinephrine?
    SULSER F; BRODIE BB
    Science; 1960 May; 131(3411):1440-1. PubMed ID: 13835663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat.
    Chen HJ; Meites J
    Endocrinology; 1975 Jan; 96(1):10-4. PubMed ID: 803259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TETRABENAZINE (NITOMAN) IN THE TREATMENT OF PSYCHOSES. WITH A DISCUSSION ON THE CENTRAL MODE OF ACTION OF TETRABENAZINE AND RESERPINE.
    LINGJAERDE O
    Acta Psychiatr Scand; 1963; 39():SUPPL170:1-109. PubMed ID: 14081399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.